<sup>18</sup>F—多巴PET在帕金森病中的应用

左传涛

¹⁸F—多巴PET在帕金森病中的应用

左传涛

文章导航 > 国际放射医学核医学杂志 > 2000, 24 > 1: (4-7)

引用本文:

Citation:

¹⁸F—多巴PET在帕金森病中的应用

左传涛

200040 上海, 上海医科大学附属华山医院核医学科

作者简介: 左传涛(1974-),男,山东青州人,上海医科大学附属华山医院核医学科住院医师,在读硕士生,主要从事PET的临床应用研究、PET计算机系统应用及开发。;

中图分类号: R742.5

The Applications of ¹⁸F-DOPA PET in Parkinson's Disease

ZUO Chuan-tao

Department of Nuclear Medicine, Huashan Hospital, Shanghai Medical University, Shanghai 200040, China
CLC number: R742.5

摘要: 黑质纹状体多巴胺能神经通路的受损是帕金森病(PD)发病机制中的主要因素,¹⁸F-多巴PET可以反映黑质纹状体神经元的结构和生化特性,这对于PD的早期诊断、鉴别诊断、病程评价和预后估计有重要的作用。
- 帕金森病 /
- ¹⁸F-多巴 /
- 正电子发射断层显像
Abstract: The injury of the presynaptic nigrostriatal dopaminergic projection is the important mechanism of Parkinson's disease(PD). ¹⁸F-DOPA PET provides a measure of the structure as well as the biochemical iategrity of the dopaminergic ueurous, which contribute to the early diagnosis, differentiation diagnosis, prognosis evaluation of PD.
- parkinson's disease /
- ¹⁸F-DOPA /
- positron emission tomography
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Shoulson I. Where do we stand on neuroprotection? Where do we go from here?[J]. Mov Disord, 1998,13:46~48.
[2]	Caparros D, Cabaret M, Codefroy O, et al. PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism[J]. J Neural Transm, 1998, 105:489~495.
[3]	Turjanski, Lees AJ, Brooks DJ, et al. Dopaminergic function in patients with posttraumatic parkinsonism:An ¹⁸F-dopa PET study[J]. Neurology, 1997, 49:183~189.
[4]	Burn DJ, Brooks DJ. Nigral dysfunction in drug-induced parkinsonism:An ¹⁸F-dopa PET study[J].Neurology, 1993, 43:552~556.
[5]	Antonini A,Leenders KL, Vontobel P, et al.Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease[J]. Brain,1997, 120:2187~2195.
[6]	Kim Y, Kim JW, Ito K, et al. Idiopathic parkinsonism with superimposed manganese exposure:utility of positron emission tomography[J].Neurotoxicology, 1999, 20:249~252.
[7]	Ito K, Morrish PK, Rakshi JS, et al. Statistical parametric mapping with ¹⁸F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 1999, 66:754~758.
[8]	Rakshi JS, Uema T, Ito K, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [¹⁸]dopa-PET study[J]. Brain, 1999, 122:1637~1650.
[9]	Vingerhoets FJG, Snow BJ, Lee CS, et al.Longitudinal flurodopa positron emission tomography studies of the evolution of idiopathic parkinsonism[J].Ann Neurol, 1994, 36:759~764.
[10]	Morrish PK, Sawle GV, Brooks DJ, et al. An ¹⁸F dopa-PET and clinical study of the rate of progressionin Parkinson's disease[J]. Brain, 1996, 119:585~591.
[11]	Morrish PK, Rakshi JS, Bailey DL, et al. Measuringthe rate of progression and estimating the preclinicalperiod of Parkinson's disease with[¹⁸]-dopa PET[J]. J Neurol Neurosurg Psychiatry, 1998, 64:314~319.
[12]	Hagell P, Schrag A, Piccini P, et al.Sequential bilateral transplantation in Parkinson's disease:effects of the second graft[J]. Brain, 1999, 122:112~132.
[13]	Defer GL, Geny C,Ricolfi F, et al. Long-termoutcome of unilaterally transplanted parkinsonian patients:I. Clinical approach[J]. Brain, 1996, 119:41~50.

[1]	李童童 , 楼菁菁 , 刘兴党 . 帕金森病心脏神经受体显像的最新研究进展. 国际放射医学核医学杂志, 2022, 46(2): 107-111. doi: 10.3760/cma.j.cn121381-202102022-00130
[2]	许靖 , 李肖红 , 秦永德 , 张奇洲 , 李毓斌 , 刘立水 , 谢彬 . 帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究. 国际放射医学核医学杂志, 2016, 40(5): 338-344. doi: 10.3760/cma.j.issn.1673-4114.2016.05.003
[3]	邓玮玮 , 张春银 . 放射性核素显像在帕金森病鉴别诊断中的应用. 国际放射医学核医学杂志, 2017, 41(2): 132-136. doi: 10.3760/cma.j.issn.1673-4114.2017.02.010
[4]	李海峰 , 张晓军 , 张锦明 . 多巴胺转运蛋白显像剂¹¹C-β-CFT在帕金森病中的应用研究. 国际放射医学核医学杂志, 2016, 40(3): 218-224. doi: 10.3760/cma.j.issn.1673-4114.2016.03.011
[5]	唐刚华 . 基因表达正电子发射断层显像. 国际放射医学核医学杂志, 2001, 25(6): 241-245.
[6]	韩贵娟 , 谢晓菲 , 宋普姣 , 王明华 . 帕金森患者脑多巴胺转运体¹¹C-CFT PET/CT显像特点的分析. 国际放射医学核医学杂志, 2022, 46(5): 270-276. doi: 10.3760/cma.j.cn121381-202202001-00174
[7]	康玉国 . 分化型甲状腺癌¹⁸F-FDG PET显像的临床应用. 国际放射医学核医学杂志, 2000, 24(6): 264-267.
[8]	闫卫红 . Raclopride在帕金森病PET中的应用. 国际放射医学核医学杂志, 2005, 29(1): 27-29.
[9]	谭海波 , 刘兴党 . PET在神经干细胞移植治疗帕金森病研究中的进展. 国际放射医学核医学杂志, 2004, 28(6): 253-256.
[10]	董爱生 , 田建明 . PET、SPECT及MRS在帕金森病诊断中的应用. 国际放射医学核医学杂志, 2005, 29(6): 244-248.